Home | Welcome to Contract Pharma   
Last Updated Tuesday, September 16 2014
Print RSS Feed

Anavex Secures cGMP Manufacture for ANAVEX Trials



Published July 21, 2014
Related Searches: cGMP Clinical Trials API Clinical Trial
Anavex Life Sciences Corp. has secured cGMP manufacture of ANAVEX 2-73 for its clinical trial supplies. Further details were not disclosed.
 
"We are delighted to have the active drug product (API) manufactured and available for our Phase IIa trial," said Christopher U. Missling, PhD, president and chief executive officer of Anavex. "We look forward to initiating clinical trials with ANAVEX PLUS for the treatment of Alzheimer's disease, which remains on track to commence in 2014 with data from the first part of the trial expected to be reported in mid 2015.”


blog comments powered by Disqus
Receive free Contract Pharma Direct emails
Sign up now to receive the weekly newsletter, and more!

Enter your email address:
Follow Contract Pharma On